Anti-Human EPHA4 Recombinant Antibody (CAT#: TAB-238CL)
Recombinant Human monoclonal antibody expressed in CHO binding to Human EPHA4. The antibodiess specific for EphA4 inhibit a cancer cell phenotype, preferentially bind epitopes on EphA4 that are selectively exposed or increased on cancer cells but not non-cancer cells and/or bind EphA4. The antibodiess are useful for hyperproliferative cell disease, particularly cancer therapy.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
Normal Tissue
Figure 1 Cerebral cortex
(Neuropil
Staining:High
Intensity: Strong
Quantity:>75%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28368/71560_B_7_5.jpg
(Neuropil
Staining:High
Intensity: Strong
Quantity:>75%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28368/71560_B_7_5.jpg
Figure 2 Cerebellum
(Molecular layer - neuropil
Staining:Medium
Intensity: Moderate
Molecular layer cells - cytoplasm/membrane
Staining:High
Intensity: Strong
Synaptic glomeruli - capsule
Staining:Medium
Intensity: Moderate
Synaptic glomeruli - core
Staining:Medium
Intensity: Moderate)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28368/71560_B_8_8.jpg
(Molecular layer - neuropil
Staining:Medium
Intensity: Moderate
Molecular layer cells - cytoplasm/membrane
Staining:High
Intensity: Strong
Synaptic glomeruli - capsule
Staining:Medium
Intensity: Moderate
Synaptic glomeruli - core
Staining:Medium
Intensity: Moderate)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28368/71560_B_8_8.jpg
Figure 3 Colon
(Enterocytes
Staining:Medium
Intensity: Moderate
Quantity: 75%-25%)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28368/71560_A_9_3.jpg
(Enterocytes
Staining:Medium
Intensity: Moderate
Quantity: 75%-25%)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28368/71560_A_9_3.jpg
Figure 4 Kidney
(Proximal tubules (cell body)
Staining:Medium
Intensity: Moderate
Quantity: 75%-25%)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28368/71560_A_9_5.jpg
(Proximal tubules (cell body)
Staining:Medium
Intensity: Moderate
Quantity: 75%-25%)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28368/71560_A_9_5.jpg
Figure 5 Testis
(Elongated or late spermatids
Staining:Medium
Intensity: Moderate
Quantity:>75%
Sertoli cells
Staining:Medium
Intensity: Moderate
Quantity:>75%)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28368/71560_A_5_6.jpg
(Elongated or late spermatids
Staining:Medium
Intensity: Moderate
Quantity:>75%
Sertoli cells
Staining:Medium
Intensity: Moderate
Quantity:>75%)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28368/71560_A_5_6.jpg
Figure 6 RNA cell line category: Cell line enhanced (AF22, ASC diff, CACO-2, U-2197)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000116106-EPHA4
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000116106-EPHA4
Specifications
- Host Species
- Human
- Type
- Antibody
- Species Reactivity
- Human
- Related Disease
- Cancer
Product Property
- Purity
- 95% by HPLC
- Storage
- Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage.
Target
- Alternative Names
- EPHA4; EPH receptor A4; SEK; HEK8; TYRO1; ephrin type-A receptor 4; EK8; EPH-like kinase 8; TYRO1 protein tyrosine kinase; tyrosine-protein kinase TYRO1; tyrosine-protein kinase receptor SEK; receptor protein-tyrosine kinase HEK8
- Gene ID
- 2043
- UniProt ID
- A0A024R452
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "EPHA4"
Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibodies
Mouse Antibodies
IgG Antibodies
ScFv Antibodies
Fab Antibodies
ScFv-Fc Chimeras
Extracellular Vesicle Antibodies
IHC Kits & Antibodies
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-386MZ | Anti-Human EPHA4 Recombinant Antibody (65) | Cyt | Human antibody |
| TAB-387MZ | Anti-Human EPHA4 Recombinant Antibody (336) | Cyt | Human antibody |
| TAB-386MZ-S(P) | Anti-Human EPHA4 Recombinant Antibody scFv Fragment (65) | FC | Human antibody |
| TAB-387MZ-S(P) | Anti-Human EPHA4 Recombinant Antibody scFv Fragment (336) | FC | Human antibody |
| TAB-386MZ-F(E) | Anti-Human EPHA4 Recombinant Antibody Fab Fragment (65) | FC | Human antibody |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-238CL. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, WB
Application: ELISA, WB, BLI, SPR
Application: ELISA, FC, WB, Block
Application: WB, ELISA, IF, FuncS, Apop, BA
Application: ELISA, FC, Inhib, FuncS
Application: ELISA, FC, Inhib
Application: Neut, ELISA, IF, IP, FuncS, FC
Application: IF, IP, Neut, FuncS, ELISA, FC
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
